Clinical Trials Browser

Terminated × Prostatic Neoplasms × pazopanib × Clear all

NCT00945477 2013-11-18

Pazopanib as Second Line Therapy in Patients With Metastatic Prostate Cancer Refractory to Total Androgen Blockade

Phase 2 Terminated

11 enrolled 6 charts

Prostatic Neoplasms